Pay in 4 interest-free payments of $6.07 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Well use this time to assess your progress, discuss any concerns or side effects, and provide ongoing support and guidance
Recent Developments: Continued expansion of Wegovy's indications, including applications for cardiovascular risk reduction
No extra nausea
Industry reporting from Clinical Trials Arena in December 2025 flagged seven additional Phase 3 readouts expected during 2026, which is consistent with a Q4 2026 or Q1 2027 submission target
doi: 10.1186/s12970-020-00396-z 10
Hypersensitivity reactions: Stop using the GLP-1 agonist and get medical help right away if you have any symptoms of a serious allergic reaction including swelling of your face, lips, tongue or throat, severe rash or itching, very rapid heartbeat, problems breathing or swallowing, fainting or feeling dizzy
